Nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenocarcinomas in Syrian golden hamsters contain beta 2-adrenergic receptor single-nucleotide polymorphisms

Genes Chromosomes and Cancer

Volumn 44, Issue 2, 2005, Pages 212-217

  Masi, Thomas ^a,b   Cekanova, Maria ^a   Walker, Kindra ^a   Bernert, Heike ^a   Majidi, Mourad ^a   Becker, Jeffrey M ^b   Schuller, Hildegard M ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; NICOTINE; NITROSAMINE; NITROSAMINE 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; UNCLASSIFIED DRUG;

ADRB2 GENE; ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CIGARETTE SMOKING; CONTROLLED STUDY; DESENSITIZATION; GENE MUTATION; HAMSTER; LIGAND BINDING; LUNG ADENOCARCINOMA; MOLECULAR CLONING; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMALS; CARCINOGENS; CRICETINAE; LUNG NEOPLASMS; MESOCRICETUS; MOLECULAR SEQUENCE DATA; NITROSAMINES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2;

ANIMALIA; MESOCRICETUS AURATUS;

EID: 24944437291     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20228     Document Type: Article

References (37)

1. Adissu HA, Schuller HM. 2004. Antagonistic growth regulation of cell lines derived from human lung adenocarcinomas of Clara cell and aveolar type TT cell lineage: implications for chemoprevention. Int J Oncol 24:1467-1472.
2. Albertine KH, Steiner RM, Radack DM, Golding DM, Peterson D, Cohn HE, Farber JL. 1998. Analysis of cell type and radiographic presentation as predictors of the clinical course of patients with bronchioalveolar cell carcinoma. Chest 113:997-1006.
3. Algazi M, Plu-Bureau G, Flahault A, Dondon MG, Le MG. 2004. [Could treatments with beta-blockers be associated with a reduction in cancer risk?]. Rev Epidemiol Sante Publique 52:53-65.
4. Broers JL, Jensen SM, Travis WD, Pass H, Whitsett JA, Singh G, Katyal SL, Gazdar AF, Minna JD, Linnoila RI. 1992. Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab Invest 66:337-346.
5. Campbell PT, Hnatowich M, O'Dowd BF, Caron MG, Lefkowitz RJ, Hausdorff WP. 1991. Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration. Mol Pharmacol 39:192-198.
6. Cheung AH, Huang RR, Strader CD. 1992. Involvement of specific hydrophobic, but not hydrophilic, amino acids in the third intracellular loop of the beta-adrenergic receptor in the activation of Gs. Mol Pharmacol 41:1061-1065.
7. Dixon RA, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, Bolanowski MA, Bennett CD, Rands E, Diehl RE, Mumford RA, Slater EE, Sigal IS, Caron MG, Lefkowitz RJ, Strader CD. 1986. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature 321:75-79.
8. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB. 2000. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97:10483-10488.
9. Gether U, Lin S, Ghanouni P, Ballesteros JA, Weinstein H, Kobilka BK. 1997. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. EMBO J 16: 6737-6747.
10. Hecht SS. 1998. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11:559-603.
11. Hecht SS. 1999a. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 424:127-142.
12. Hecht SS. 1999b. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194-1210.
13. Hecht SS. 2002. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3:461-469.
14. Hoffmann D, Hoffmann I, El-Bayoumy K. 2001. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 14:767-790.
15. Huang XE, Hamajima N, Saito T, Matsuo K, Mizutani M, Iwata H, Iwase T, Miura S, Mizuno T, Tokudome S, Tajima K. 2001. Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer. Breast Cancer Res 3:264-269.
16. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. 2004. Cancer statistics, 2004. CA Cancer J Clin 54:8-29.
17. Jensen AD, Guarnieri F, Rasmussen SG, Asmar F, Ballesteros JA, Gether U. 2001. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling. J Biol Chem 276:9279-9290.
18. Kobilka BK, Frielle T, Dohlman HG, Bolanowski MA, Dixon RA, Keller P, Caron MG, Lefkowitz RJ. 1987. Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J Biol Chem 262:7321-7327.
19. Kristiansen K. 2004. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103:21-80.
20. Leineweber K, Brodde OE. 2004. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes. Life Sci 74:2803-2814.
21. Liggett SB, Caron MG, Lefkowitz RJ, Hnatowich M. 1991. Coupling of a mutated form of the human beta 2-adrenergic receptor to Gi and Gs. Requirement for multiple cytoplasmic domains in the coupling process. J Biol Chem 266:4816-4821.
22. Liggett SB. 2003. Polymorphisms of adrenergic receptors: variations on a theme. Assay Drug Dev Technol 1:317-326.
23. Meyerson M, Franklin WA, Kelley MJ. 2004. Molecular classification and molecular genetics of human lung cancers. Semin Oncol 31:4-19.
24. O'Dowd BF, Hnatowich M, Regan JW, Leader WM, Caron MG, Lefkowitz RJ. 1988. Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. J Biol Chem 263:15985-15992.
25. Patel JD, Bach PB, Kris MG. 2004. Lung cancer in US women: a contemporary epidemic. JAMA 291:1763-1768.
26. Rehm S, Takahashi M, Ward JM, Singh G, Katyal SL, Henneman JR. 1989. Immunohistochemical demonstration of Clara cell antigen in lung tumors of bronchiolar origin induced by N-nitrosodiethylamine in Syrian golden hamsters. Am J Pathol 134:79-87.
27. Schuller HM, Witschi HP, Nylen E, Joshi PA, Correa E, Becker KL. 1990. Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone and the modulating effect of hyperoxia. Cancer Res 50:1960-1965.
28. Schuller HM, Tithof PK, Williams M, Plummer H, 3rd. 1999. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res 59: 4510-4515.
29. Schuller HM, Porter B, Riechert A. 2000. Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters. J Cancer Res Clin Oncol 126:624-630.
30. Schuller HM. 2002. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2:455-463.
31. Schuller HM, Porter B, Riechert A, Walker K, Schmoyer R. 2004. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers. Lung Cancer 45:11-18.
32. Small KM, Tanguay DA, Nandabalan K, Zhan P, Stephens JC, Liggett SB. 2003. Gene and protein domain-specific patterns of genetic variability within the G-protein coupled receptor superfamily. Am J Pharmacogenomics 3:65-71.
33. Takezaki T, Hamajima N, Matsuo K, Tanaka R, Hirai T, Kato T, Ohashi K, Tajima K. 2001. Association of polymorphisms in the beta-2 and beta-3 adrenoceptor genes with risk of colorectal cancer in Japanese. Int J Clin Oncol 6:117-122.
34. Thun MJ, Lally CA, Flannery JT, Galle EE, Flanders WD, Heath CW, Jr. 1997. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 89:1580-1586.
35. Tithof PK, Elgayyar M, Schuller HM, Barnhill M, Andrews R. 2001. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine derivative, induces apoptosis of endothelial cells. Am J Physiol Heart Circ Physiol 281:H1946-1954.
36. Yokota J, Kohno T. 2004. Molecular footprints of human lung cancer progression. Cancer Sci 95:197-204.
37. Zabarovsky ER, Lerman MI, Minna JD. 2002. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21:6915-6935.